{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:21:22Z","timestamp":1788664882877,"version":"build-2803163510"},"reference-count":53,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundaci\u00f3n Conde de Valenciana, Novartis, Consejo Nacional de Ciencia y Tecnolog\u00eda","award":["Proyectos de Desarrollo Cient\u00edfico para Atender Problemas Nacionales 2013 project 214718"],"award-info":[{"award-number":["Proyectos de Desarrollo Cient\u00edfico para Atender Problemas Nacionales 2013 project 214718"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Introduction: Major depressive disorder (MDD) is a common comorbidity of type 2 diabetes (T2D) with low rates of treatment response to antidepressants. The pathophysiology of these conditions overlaps in N-methyl-d-aspartate receptors (NMDARs), which are present in neurons and pancreatic cells. GRIN1 encodes NMDARs and has been associated with depression and T2D; however, its role in the coexistence of MDD and T2D and the treatment response to antidepressants has yet to be explored. Objective: We aimed to evaluate the association between GRIN1 rs28489906 and MDD and treatment response to antidepressants in patients with T2D. Methods: A prospective study was conducted on T2D patients enrolled in a comprehensive care program with follow-up at 3 months. Subjects were assessed for MDD, and genotyping for GRIN1 rs28489906 was performed. Depression scores and glycated hemoglobin (HbA1c) were analyzed using the Wilcoxon paired signed-rank test, and a stratified analysis was conducted to assess treatment response. Logistic regression analyses were performed to predict MDD and treatment response. Results: Our sample included 232 patients; among them, 49 (21%) had MDD. Patients with MDD showed a higher frequency of the AA genotype compared with non-MDD subjects (p = 0.026). A allele carriers reported lower treatment response rates (p = 0.049) and decreased odds of treatment response (OR = 0.03, 95% CI 0.002\u20130.63, p = 0.023). Patients with AG and AA genotypes with treatment response exhibited lower HbA1c (p = 0.029). Conclusions: The A allele of GRIN1 rs28489906 was associated with MDD and treatment response in patients with T2D. Our findings highlight the role of glutamate in these comorbidities and the need for different therapeutic approaches based on genetics.<\/jats:p>","DOI":"10.3390\/brainsci16030268","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:52:38Z","timestamp":1772207558000},"page":"268","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association Between GRIN1 rs28489906 and Major Depressive Disorder and Treatment Response to Antidepressants in Patients with Type 2 Diabetes"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9248-0472","authenticated-orcid":false,"given":"Alejandra Monserrat","family":"Rodr\u00edguez-Ram\u00edrez","sequence":"first","affiliation":[{"name":"Centro de Atenci\u00f3n Integral del Paciente con Diabetes (CAIPaDi), Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"},{"name":"Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Benitez-Valenzuela","sequence":"additional","affiliation":[{"name":"Centro de Atenci\u00f3n Integral del Paciente con Diabetes (CAIPaDi), Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Alc\u00e1ntara-Garc\u00e9s","sequence":"additional","affiliation":[{"name":"Centro de Atenci\u00f3n Integral del Paciente con Diabetes (CAIPaDi), Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7722-5940","authenticated-orcid":false,"given":"Marco Antonio","family":"Sanabrais-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Departamento de Farmacogen\u00e9tica, Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz, Mexico City 14370, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9685-6847","authenticated-orcid":false,"given":"Julio Uriel","family":"Zaragoza-Hoyos","sequence":"additional","affiliation":[{"name":"Departamento de Farmacogen\u00e9tica, Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz, Mexico City 14370, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Del Valle-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Centro de Atenci\u00f3n Integral del Paciente con Diabetes (CAIPaDi), Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Hernandez-Romero","sequence":"additional","affiliation":[{"name":"Departamento de Farmacogen\u00e9tica, Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz, Mexico City 14370, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Rojas-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Garc\u00eda-Ulloa","sequence":"additional","affiliation":[{"name":"Centro de Atenci\u00f3n Integral del Paciente con Diabetes (CAIPaDi), Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Camarena-Medellin","sequence":"additional","affiliation":[{"name":"Departamento de Farmacogen\u00e9tica, Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz, Mexico City 14370, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dme.14042","article-title":"Prevalence of Comorbid Major Depressive Disorder in Type 2 Diabetes: A Meta-Analysis of Comparative and Epidemiological Studies","volume":"36","author":"Wang","year":"2019","journal-title":"Diabet. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2147\/NDT.S364556","article-title":"Comorbidity Between Recent Diagnosis of Type 2 Diabetes and Non-Psychotic Psychiatric Disorders: Metabolic Characteristics and Clinical Correlates","volume":"18","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2337\/dc16-2018","article-title":"Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations with Mortality Risk","volume":"40","author":"Naicker","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.diabres.2016.10.023","article-title":"Lifetime Depression and Anxiety Increase Prevalent Psychological Symptoms and Worsen Glycemic Control in Type 2 Diabetes: The Fremantle Diabetes Study Phase II","volume":"122","author":"Whitworth","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/dme.13372","article-title":"Depression Symptoms Are Persistent in Type 2 Diabetes: Risk Factors and Outcomes of 5-Year Depression Trajectories Using Latent Class Growth Analysis","volume":"34","author":"Whitworth","year":"2017","journal-title":"Diabet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/dc06-1769","article-title":"Factors Influencing Glycemic Control in Type 2 Diabetes during Acute- and Maintenance-Phase Treatment of Major Depressive Disorder with Bupropion","volume":"30","author":"Lustman","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/dc09-1466","article-title":"Antidepressant Pharmacotherapy in Adults with Type 2 Diabetes: Rates and Predictors of Initial Response","volume":"33","author":"Anderson","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a Glutamate Hypothesis of Depression: An Emerging Frontier of Neuropsychopharmacology for Mood Disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate Receptor Ion Channels: Structure, Regulation, and Function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.3822","article-title":"Characterization of Pancreatic NMDA Receptors as Possible Drug Targets for Diabetes Treatment","volume":"21","author":"Marquard","year":"2015","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.33549\/physiolres.935346","article-title":"Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B Genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology","volume":"73","author":"Korinek","year":"2024","journal-title":"Physiol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s11033-020-05304-x","article-title":"The Association between Eating Behavior and Polymorphisms in GRIN2B, GRIK3, GRIA1 and GRIN1 Genes in People with Type 2 Diabetes Mellitus","volume":"47","author":"Kochetova","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/YPG.0b013e3280c1e5fb","article-title":"Possible Association between Genetic Variants at the GRIN1 Gene and Schizophrenia with Lifetime History of Depressive Symptoms in a German Sample","volume":"17","author":"Georgi","year":"2007","journal-title":"Psychiatr. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6851592","DOI":"10.1155\/2016\/6851592","article-title":"Influence of Genetic Variants of the N-Methyl-D-Aspartate Receptor on Emotion and Social Behavior in Adolescents","volume":"2016","author":"Lee","year":"2016","journal-title":"Neural Plast."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-024-01114-y","article-title":"Glutamatergic Modulators for Major Depression from Theory to Clinical Use","volume":"38","author":"McIntyre","year":"2024","journal-title":"CNS Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41398-025-03234-5","article-title":"The Interface of Depression and Diabetes: Treatment Considerations","volume":"15","author":"Fanelli","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e14497","DOI":"10.1111\/cns.14497","article-title":"Neurological and Metabolic Related Pathophysiologies and Treatment of Comorbid Diabetes with Depression","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.diabres.2019.04.009","article-title":"Long-Term Effectiveness of a Type 2 Diabetes Comprehensive Care Program. The CAIPaDi Model","volume":"151","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142025","volume":"48","author":"Committee","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142025","volume":"48","author":"Committee","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ameican Psychiatry Association (2022). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association Publishing.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"ref_23","unstructured":"Ferrando, L., Bobes, J., and Gibert, J.M.I.N.I. (1998). Mini International Neuropsychiatric Interview. Versi\u00f3n en Espa\u00f1ol, Instituto IAP."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_25","unstructured":"Heinze, G., Pedro, M., Segura, C., Berenzon, S., Del Bosque, J., Alfaro, J., and Medina-Mora, M.E. (2010). CL\u00cdNICAS PARA LA ATENCI\u00d3N DE TRASTORNOS MENTALES Gu\u00eda Cl\u00ednica Para El Manejo de La Depresi\u00f3n, Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for Mood Disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0924-9338(97)83296-8","article-title":"The Mini International Neuropsychiatric Interview (MINI). A Short Diagnostic Structured Interview: Reliability and Validity According to the CIDI","volume":"12","author":"Lecrubier","year":"1997","journal-title":"Eur. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The Validity of the Hospital Anxiety and Depression Scale","volume":"52","author":"Bjelland","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/dme.13611","article-title":"Prevalence and Correlates of Depressive Disorders in People with Type 2 Diabetes: Results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) Study, a Collaborative Study Carried out in 14 Countries","volume":"35","author":"Lloyd","year":"2018","journal-title":"Diabet. Med."},{"key":"ref_30","first-page":"101","article-title":"[Prevalence and Gravity of Depression and Anxiety in Patients with Obesity and Type 2 Diabetes: A Study in the Population of Tabasco, Mexico]","volume":"150","year":"2014","journal-title":"Gac. Med. Mex."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.diabres.2014.01.001","article-title":"Depression and Type 2 Diabetes in Low and Middle Income Countries: A Review","volume":"103","author":"Mendenhall","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5498\/wjp.v12.i7.884","article-title":"Genetic Variables of the Glutamatergic System Associated with Treatment-Resistant Depression: A Review of the Literature","volume":"12","author":"Saez","year":"2022","journal-title":"World J. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, Function, and Allosteric Modulation of NMDA Receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1113\/jphysiol.2014.273763","article-title":"Molecular Bases of NMDA Receptor Subtype-Dependent Properties","volume":"593","author":"Glasgow","year":"2015","journal-title":"J. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Degtyareva, A.O., Antontseva, E.V., and Merkulova, T.I. (2021). Regulatory Snps: Altered Transcription Factor Binding Sites Implicated in Complex Traits and Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126454"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","article-title":"JASPAR 2022: The 9th Release of the Open-Access Database of Transcription Factor Binding Profiles","volume":"50","author":"Rauluseviciute","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41593-019-0462-8","article-title":"Stress Resilience Is Promoted by a Zfp189-Driven Transcriptional Network in Prefrontal Cortex","volume":"22","author":"Lorsch","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting P53 Pathways: Mechanisms, Structures, and Advances in Therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Maeso-Alonso, L., L\u00f3pez-Ferreras, L., Marques, M.M., and Marin, M.C. (2021). P73 as a Tissue Architect. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.716957"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/hsz-2022-0236","article-title":"NMDA Receptors\u2014Regulatory Function and Pathophysiological Significance for Pancreatic Beta Cells","volume":"404","author":"Gresch","year":"2023","journal-title":"Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e063095","DOI":"10.1136\/bmjopen-2022-063095","article-title":"What Are the Treatment Remission, Response and Extent of Improvement Rates after up to Four Trials of Antidepressant Therapies in Real-World Depressed Patients? A Reanalysis of the STAR\u2217D Study\u2019s Patient-Level Data with Fidelity to the Original Research Protocol","volume":"13","author":"Pigott","year":"2023","journal-title":"BMJ Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1017\/S0033291715002445","article-title":"Depressive Symptoms and Glycated Hemoglobin A1c: A Reciprocal Relationship in a Prospective Cohort Study","volume":"46","author":"Schmitz","year":"2016","journal-title":"Psychol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apcsb.2015.10.003","article-title":"Glutamatergic NMDA Receptor as Therapeutic Target for Depression","volume":"103","author":"Abelaira","year":"2016","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ygeno.2020.12.030","article-title":"Treatment Response to Low-Dose Ketamine Infusion for Treatment-Resistant Depression: A Gene-Based Genome-Wide Association Study","volume":"113","author":"Chen","year":"2021","journal-title":"Genomics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pscychresns.2009.02.005","article-title":"Glutamate Receptor Gene (GRIN2B) Associated with Reduced Anterior Cingulate Glutamatergic Concentration in Pediatric Obsessive-Compulsive Disorder","volume":"172","author":"Arnold","year":"2009","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00213-013-3297-0","article-title":"A Study of N-Methyl-D-Aspartate Receptor Gene (GRIN2B) Variants as Predictors of Treatment-Resistant Major Depression","volume":"231","author":"Zhang","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.2337\/diacare.27.9.2154","article-title":"Relationship of Depression and Diabetes Self-Care, Medication Adherence, and Preventive Care","volume":"27","author":"Lin","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13651501.2021.1957117","article-title":"Diabetes and Mood Disorders: Shared Mechanisms and Therapeutic Opportunities","volume":"26","author":"Martins","year":"2022","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tem.2015.12.004","article-title":"Exciting Times for Pancreatic Islets: Glutamate Signaling in Endocrine Cells","volume":"27","author":"Otter","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/dom.13017","article-title":"NMDAR Antagonists for the Treatment of Diabetes Mellitus\u2014Current Status and Future Directions","volume":"19","author":"Welters","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.dsx.2019.02.010","article-title":"Association between Depression with Glycemic Control and Its Complications in Type 2 Diabetes","volume":"13","author":"Mansori","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2020.12.074","article-title":"Insulin Resistance Is Associated with Deficits in Hedonic, Self-Reported Cognitive, and Psychosocial Functional Response to Antidepressant Treatment in Individuals with Major Depressive Disorder","volume":"282","author":"Rashidian","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_53","first-page":"1","article-title":"Gu\u00edas ALAD Sobre El Diagn\u00f3stico, Control Y Tratamiento de La Diabetes Mellitus Tipo 2 con Medicina Basada En Evidencia Edici\u00f3n","volume":"9","author":"Aschner","year":"2019","journal-title":"Rev. Asoc. Latinoam. Diabetes"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/3\/268\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:31:33Z","timestamp":1772461893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/3\/268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["brainsci16030268"],"URL":"https:\/\/doi.org\/10.3390\/brainsci16030268","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}